T-maximum Pharmaceutical Inc

This study is testing an experimental cell therapy called MT027 for adults with glioblastoma, a fast-growing brain cancer, that has come back or gotten worse after standard treatment. The therapy is injected directly into the fluid-filled spaces of the brain. The main goals are t…